Windlesham1
Established member
- Messages
- 532
- Likes
- 60
I'll be there looking suspiciously like my avatar!
Dear Registrant,
The World Money Show London is only a short time away, 29-30 September, at the QEII Conference Centre, and will prove to be a fantastic opportunity to gather with fellow private investors, traders, and financial advisers.
For those of you who registered before 28 August, you should have received your confirmation packet in the post, which includes your name badge and confirmation letter. When you arrive at The World Money Show London, please stop at the Delegate Desk in order to receive your onsite materials, which include a Daily Program and Resource Directory. If you registered on or after 28 August, you can pick up your name badge at the Delegate desk at the Show.
If you have not done so already, please take the opportunity to visit the World Money Show London Web site, at http://www.WorldMoneyShowLondon.co.uk. The Web site is updated daily, and features the most up-to-date speaker schedules and topics, and exhibitor list.
And if you visit our online schedule of events, you can plan your schedule before you arrive at the Show! Decide which speakers and exhibitors you want to see, what you want to learn, and determine where workshops will be located—before you arrive at Show! To view the online schedule of events, go here.
While you’re planning your schedule, take the time to look at the optional tuition-paid intensive seminars we’re offering at the show. Purchase a ticket for tuition-paid intensive seminars and further enhance your experience at the Show. To purchase tickets to tuition-paid intensive seminars at the Show, go here.
For complete details, or if you would like to purchase a ticket to one of our optional paid events, contact one of our Client Services Representatives TODAY at 00 800 1414 8888 (international freephone) between 10:30 – 22:30 BST , or visit us online at:
http://www.WorldMoneyShowLondon.co.uk
We look forward to seeing you soon at the Show!
Sincerely,
Marc Sproul
Client Services Manager
InterShow—Producers of The World Money Show
The World Money Show London is only a short time away, 29-30 September, at the QEII Conference Centre, and will prove to be a fantastic opportunity to gather with fellow private investors, traders, and financial advisers.
For those of you who registered before 28 August, you should have received your confirmation packet in the post, which includes your name badge and confirmation letter. When you arrive at The World Money Show London, please stop at the Delegate Desk in order to receive your onsite materials, which include a Daily Program and Resource Directory. If you registered on or after 28 August, you can pick up your name badge at the Delegate desk at the Show.
If you have not done so already, please take the opportunity to visit the World Money Show London Web site, at http://www.WorldMoneyShowLondon.co.uk. The Web site is updated daily, and features the most up-to-date speaker schedules and topics, and exhibitor list.
And if you visit our online schedule of events, you can plan your schedule before you arrive at the Show! Decide which speakers and exhibitors you want to see, what you want to learn, and determine where workshops will be located—before you arrive at Show! To view the online schedule of events, go here.
While you’re planning your schedule, take the time to look at the optional tuition-paid intensive seminars we’re offering at the show. Purchase a ticket for tuition-paid intensive seminars and further enhance your experience at the Show. To purchase tickets to tuition-paid intensive seminars at the Show, go here.
For complete details, or if you would like to purchase a ticket to one of our optional paid events, contact one of our Client Services Representatives TODAY at 00 800 1414 8888 (international freephone) between 10:30 – 22:30 BST , or visit us online at:
http://www.WorldMoneyShowLondon.co.uk
We look forward to seeing you soon at the Show!
Sincerely,
Marc Sproul
Client Services Manager
InterShow—Producers of The World Money Show
stevespray
Experienced member
- Messages
- 1,289
- Likes
- 156
MarvinS said:
Wasn't this mentioned in the Sunday Times last weekend? I'm surprised it didn't rate a mention sooner.
Steve.
stevespray
Experienced member
- Messages
- 1,289
- Likes
- 156
MarvinS said:
The forum's section on the spoof site seems quite funny.
Steve.
Dear Attendee,
We look forward to sharing information about our company at the London Money Show, September 29-30, 2006, that is being held at the QE II Conference Centre. CardioVascular BioTherapeutics, Inc. (CVBT) is a biopharmaceutical company solely focused on its drug candidate Cardio Vascu-Grow™. This potent protein growth factor stimulates the growth of new blood vessels, a biological process termed “angiogenesis.” It is currently being tested in a wide variety of human diseases that would benefit from increased blood flow including coronary artery disease, stroke, and peripheral vascular disease of the legs and wound healing.
Heart Disease
Growing new blood vessels around blocked arteries.
13 million patients with coronary artery disease
• Celebrating 10-year anniversary of first treated human patients
• FDA Phase I results - appears to be a safe and well tolerated treatment for coronary artery disease
• Ethical data consistent with prior human clinical results
• Continuing FDA clinical trials in patients
We look forward to sharing information about our company at the London Money Show, September 29-30, 2006, that is being held at the QE II Conference Centre. CardioVascular BioTherapeutics, Inc. (CVBT) is a biopharmaceutical company solely focused on its drug candidate Cardio Vascu-Grow™. This potent protein growth factor stimulates the growth of new blood vessels, a biological process termed “angiogenesis.” It is currently being tested in a wide variety of human diseases that would benefit from increased blood flow including coronary artery disease, stroke, and peripheral vascular disease of the legs and wound healing.
Heart Disease
Growing new blood vessels around blocked arteries.
13 million patients with coronary artery disease
• Celebrating 10-year anniversary of first treated human patients
• FDA Phase I results - appears to be a safe and well tolerated treatment for coronary artery disease
• Ethical data consistent with prior human clinical results
• Continuing FDA clinical trials in patients
Similar threads
